Masimo (MASI) Cash from Investing Activities (2009 - 2026)

Masimo's (MASI) quarterly Cash from Investing Activities came in at -$4.2 million in Q2 2026, down 139.25% year-on-year from $10.7 million in Q2 2025, and up 51.72% quarter-over-quarter from -$8.7 million in Q1 2026.

Masimo (MASI) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Masimo's Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$4.2 million for Q2 2026.

  • On a quarterly basis, Cash from Investing Activities fell 139.25% year-over-year to -$4.2 million in Q2 2026; TTM through Apr 2026 was -$18.3 million, a 438.24% decrease from a year earlier, with the FY2026 full-year figure at -$3.4 million, up 86.35% from the prior year.
  • Cash from Investing Activities improved to -$4.2 million in Q2 2026 per MASI's latest filing, from -$8.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $43.3 million in Q1 2022 and bottomed at -$1.0 billion in Q3 2022.
  • The 5-year median for Cash from Investing Activities is -$8.2 million (2022), against an average of -$61.6 million.
  • Across the five-year window, Cash from Investing Activities tumbled 190.91% in 2023 and jumped 242.03% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$22.8 million in 2022, then jumped by 69.74% to -$6.9 million in 2023, then soared by 242.03% to $9.8 million in 2024, then plunged by 154.08% to -$5.3 million in 2025, then grew by 20.75% to -$4.2 million in 2026.
  • Per Business Quant, the three latest MASI Cash from Investing Activities figures stand at -$4.2 million (Q2 2026), -$8.7 million (Q1 2026), and -$5.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Masimo 9.39 Bn 9.27 Bn 250.80 Mn -4.20 Mn

Historic Data

Download Data
DateValue
Apr 4, 2026 -4.20 Mn
Apr 4, 2026 -4.20 Mn
Jan 3, 2026 -8.70 Mn
Jan 3, 2026 -8.70 Mn
Sep 27, 2025 -5.30 Mn
Sep 27, 2025 -5.30 Mn
Jun 28, 2025 -100,000.00
Jun 28, 2025 -100,000.00
Mar 29, 2025 10.70 Mn
Mar 29, 2025 10.70 Mn
Dec 28, 2024 9.80 Mn
Dec 28, 2024 9.80 Mn
Sep 28, 2024 -26.60 Mn
Sep 28, 2024 -26.60 Mn
Jun 29, 2024 2.70 Mn
Jun 29, 2024 2.70 Mn
Mar 30, 2024 -10.80 Mn
Mar 30, 2024 -10.80 Mn
Dec 30, 2023 -6.90 Mn
Dec 30, 2023 -6.90 Mn